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OBJECTIVES: The number of pancreatic transplants has decreased in recent years. Pancreatic grafts have been
underutilized compared to other solid grafts. One cause of discard is the macroscopic appearance of the
pancreas, especially the presence of fatty infiltration. The current research is aimed at understanding any graft-
related association between fatty tissue infiltration of the pancreas and liver steatosis.
METHODS: From August 2013 to August 2014, a prospective cross-sectional clinical study using data from
54 multiple deceased donor organs was performed.
RESULTS: Micro- and macroscopic liver steatosis were significantly correlated with the donor body mass index
([BMI]; p=0.029 and p=0.006, respectively). Positive gamma associations between pancreatic and liver macroscopic
and microscopic findings (0.98; confidence interval [CI]: 0.95–1 and 0.52; CI 0.04–1, respectively) were observed.
Furthermore, comparisons of liver microscopy findings showed significant differences between severe versus absent
(po0.001), severe versus mild (po0.001), and severe versus moderate classifications (po0.001). The area under the
receiver operating curve was 0.94 for the diagnosis of steatosis by BMI evaluation using a cut-off BMI of 27.5 kg/m2,
which yielded 100% sensitivity, 87% specificity, and 100% negative predictive value.
CONCLUSIONS:We observed a positive association of macroscopic and microscopic histopathological findings in
steatotic livers with adipose infiltration of pancreatic grafts.
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’ INTRODUCTION
The total number of pancreatic transplants performed in
the United States has decreased since 2004 (1,2). Pancreatic
grafts have been underutilized compared to other solid organs,
and the rates of pancreatic discard and non-procurement have
increased (3). One cause of discard is a poor macroscopic
appearance of the pancreas, mainly due to fatty infiltration of
the organ.
Pancreatic graft adipose infiltration (PGAI) can be hazar-
dous for whole pancreas transplant recipients. Since PGAI
can increase postoperative complications, such as pancrea-
titis and pancreatic graft thrombosis, and cause a decrease
in graft survival, many transplant teams discard the organ
following macroscopic evaluation. However, macroscopic
pancreatic examinations can be difficult due to the presence
of peripancreatic adipose tissue, which leads to inaccurate
evaluation of adipose infiltration into the pancreas (2,4,5).
Pancreatic biopsy can be hazardous for pancreatic patients
due to postoperative pancreatitis and fistula.
In contrast, liver graft steatosis is easily analyzed from
both the macroscopic and microscopic points of view. Liver
biopsy is very accurate (6), and steatosis can be classified
as micro- or macrovesicular. Macrovesicular steatosis has a
greater influence on ischemia/reperfusion injury and poor
graft function than microvesicular steatosis, which occasion-
ally occurs in isolated cases (5,6). During the organ recovery
period, macrovesicular steatosis is generally suspected after
the initial inspection. However, biopsy is the gold standard
used to obtain an objective assessment (7). Furthermore, fatty
tissue infiltration into pancreatic grafts does not undergo this
type of evaluation.
Ninety percent of the organs used for whole organ pan-
creatic transplant are obtained from donors o50 years old
with a body mass index (BMI) o30 kg/m2, while organs
from older, more obese donors are more often recoveredDOI: 10.6061/clinics/2018/e49
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for islet transplantation or research (8). Another important
factor observed when a pancreatic graft is refused is fatty
tissue infiltration of the pancreas, which is the motivation for
this study.
Our intention was to verify the association between
PGAI and liver steatosis. We speculated that PGAI could
be indirectly evaluated by liver graft analysis, thus avoiding
organ discard and facilitating an evaluation of the pancreatic
graft. The main objective of this study was to evaluate the
association of the degree of fatty infiltration of the pancreatic
graft with the degree of hepatic steatosis in multiple deceased
donor organs.
’ MATERIALS AND METHODS
Study design
From August 2013 to August 2014, we analyzed clinical
data from 54 multiple deceased donor organs in the Depart-
ment of Gastroenterology at the University of Sao Paulo
School of Medicine, Brazil. We prospectively studied, compared,
and evaluated the associations among demographic, clinical,
and laboratory data from deceased donors.
Inclusion and exclusion criteria
All deceased liver donors that were transplanted in our
service during the study period were included. To comply
with the wishes of the ethical committee, we included graft
cases not previously used for other reasons (age, BMI,
comorbidities, drugs) to avoid interfering with the evolu-
tion of the graft. All members of the family of the deceased
donor and the recipients agreed to the study protocol and
provided informed consent.
Donor technique definition
In all cases, we performed total hepatectomy en bloc in
conjunction with the pancreas as the conventional organ
recovery donor surgery. Preservation was performed using
the University of Wisconsin solution (UW). We performed a
liver and pancreatic biopsy, which was sent to the pathology
department for microscopic study. A board-certified expert
surgeon with extensive experience in pancreatic and liver
transplant performed a macroscopic evaluation and classified
the degree of liver steatosis and pancreatic liposubstitution
as absent, mild (0%–30%), moderate (31%–70%), or severe
(470%). The associations between these factors were
determined.
Histopathology
Fifty-four segments of pancreatic tissue between 3.0 and
5.0 cm in diameter (with no transplanted pancreatic graft)
and liver biopsy (with transplanted hepatic grafts) specimens
were obtained using a Tru-Cut biopsy needle 14G (Langeskov,
Denmark). The segments were fixed in 10% formalin and
sent to the pathology division for macroscopic evalua-
tion. Three fragments were chosen, thereby generating
three blocks each per case. The material was processed and
embedded in a paraffin mold until it had completely
solidified. Four-micrometer sections were cut, placed on a
slide, and stained with hematoxylin and eosin. The eval-
uation was performed by the same pathologist (a board-
certified expert pathologist with extensive experience in
hepatobiliary and liver transplant) without knowledge of
clinical information and prior macroscopic evaluation of
formaldehyde-fixed sections. Fatty replacements of the
pancreatic parenchyma and liver steatosis were evaluated as
pathological parameters (Figure 1).
Statistical analysis
Median (25%–75% quantile) or mean and standard devia-
tion values are presented for quantitative variables, and
percentages are presented for categorical variables. Gamma
ordinal association (strong 40.7, moderate o0.7 and 40.4,
and lowo0.4) was performed between categorical variables (9).
Analysis of variance followed by the Tukey or Kruskal-Wallis
test followed by the non-parametric Tukey test were applied
to analyze differences among groups (10). Finally, a receiver
operating characteristic (ROC) curve was used to determine
cutoff points for examination values. All analyses were con-
ducted with the R statistical program, version 2.15.1 (11).
A value of po0.05 was considered statistically significant in
the final analysis.
Ethical aspects
The study was approved by the Institutional Review
Ethics and Research (Cappesq) committee of the Hospital das
Clinicas HCFMUSP, Faculdade de Medicina, Universidade
de São Paulo, number 399.857, on 18/07/2013, fulfilling all
requirements for studies on humans according to the guide-
lines of the 1975 Helsinki Declaration.
’ RESULTS
Clinical and demographic profile of the population
Clinical data from 54 deceased donors from August 2013 to
August 2014 were studied. The mean donor age was 40.82±
17.24 years, and the median age was 43 (ranging from 5 to 71)
years. The mean donor BMI was 24.38±4.38, and the median
was 24 (ranging from 15.3 to 31). Moreover, the surgeon
evaluated macroscopic steatosis and adipose infiltration into the
pancreas for the classification of subtypes as shown in Table 1.
The macroscopic evaluation of liver steatosis cases showed
that steatosis was absent in 42.86%, mild in 39.29%, mode-
rate in 14.29%, and severe in 3.57% of cases. Pancreatic
macroscopic liposubstitution was absent in 36.36%, mild in
30.3%, moderate in 27.27%, and severe in 6.06% of cases.
The microscopic evaluation indicated no steatosis in 40%,
mild steatosis in 42%, moderate steatosis in 10%, and severe
in steatosis 8% of cases. Pancreatic microscopic liposubstitu-
tion was absent in 13.33%, mild in 80%, moderate in 10%,
and severe in 8% of cases.
The demographic associations between the liver and pan-
creatic macroscopic and microscopic evaluations are shown
in Figure 1, and multiple comparisons and analyses are
shown in Table 2.
Group comparisons and associations
Gamma ordinal association was performed between cate-
gorical variables. Table 3 shows a significant association
between pancreatic and liver macroscopic findings (0.98;
CI 0.95–1) and between pancreatic and liver microscopic
findings (0.52; CI 0.04–1). Tests were applied to determine
differences among groups, as shown in Table 3. The results
in Table 2 demonstrate statistically significant associations
of microscopic and macroscopic liver steatosis with donor
BMI (0.029 and 0.006, respectively). Multiple comparison tests
for variable donor BMI are shown in Table 4, which demon-
strates a significant association of macroscopic liver steato-
sis between the moderate and absent groups (p=0.030).
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Furthermore, a comparison of liver microscopic findings
showed significant differences between the severe versus
absent (po0.001), severe versus mild (po0.001), and severe
versus moderate groups (po0.001), as shown in Table 4.
ROC curve analysis
The area under the ROC curve (AUROC) of 0.94 demon-
strates an excellent fit, as shown in Figure 2. This finding
indicates an improved steatosis diagnosis corresponding to
BMI evaluation. The ROC curve revealed an optimal BMI
cut-off value of 27.5 kg/m2, with a sensitivity of 100%, speci-
ficity of 87%, negative predictive value 100%, and positive
predictive value of 40% (Figure 2).
’ DISCUSSION
In this study, we observed a positive association between
macroscopic evaluation by a surgeon and microscopic patho-
logic findings in relation to steatotic liver and adipose infil-
tration of pancreatic grafts. Furthermore, we determined
the optimal donor BMI value for predicting steatosis and
adipose infiltration of the pancreatic graft.
Stratta et al. discussed several methods to alleviate the
decrease in pancreatic transplants (2), including expanding
the number of acceptable donors (2). The present study may
facilitate the process of pancreatic transplant by improving
the evaluation of the association between pancreatic graft
and liver biopsy. We found a positive association between
macroscopic and microscopic findings in relation to steatotic
liver and adipose infiltration of the pancreatic graft. This
finding indicates that macroscopic findings should be com-
pared with the microscopic findings. Furthermore, pancreatic
grafts do not have to be discarded based on possible mistakes
by the surgeon who interprets the macro/microscopic results.
Table 1 - Demographic parameters for all deceased donors
evaluated.
Parameters Deceased donor (n=54)
Sex (n/%) M=34 (62.9%) / F=20 (37.1)
Mean age (years) 40.82±17.24
Median age (years) 43 (range, 5-71)
Mean donor BMI 24.38±4.38
Median donor BMI 24 (range, 15.3-31)
























Note: BMI, Body mass index; Surgeon, macroscopy; Pathology, microscopy.
Figure 1 - Illustration of microscopic pathologic findings: (A) mild and (B) moderate pancreatic graft adipose infiltration and (C) moderate
and (D) severe steatotic liver.
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In this situation, we suggest confirming the association of the
pancreatic histopathology analysis with the liver biopsy.
A growing obesity epidemic coupled with a high dia-
betes prevalence in the general population can cause hepatic
steatosis and likely causes fatty tissue infiltration of the
pancreas (4). This is one of the donor characteristics that is
termed ‘‘marginal.’’ This situation is increasingly common
and interferes with graft procurement (4). Additional donors,
based on recently expanded criteria, are desired due to organ
shortages and a constant imbalance between available
organs and transplant candidates. The literature shows that
variations occur in the definitions, selection criteria, and use
of expanded criteria donors according to different geogra-
phical areas and centers based on the acceptable risk of graft
failure (4,5).
Cucchetti A et al. analyzed data from 374 deceased liver
donors from whom a liver biopsy had been obtained to iden-
tify variables that could predict the degree of macrovesicular
steatosis. Steatosis could be identified accurately to a level of
430% with an AUC of 0.86 (95% CI=0.81–0.91) in combina-
tion with BMI, an elevation of alanine aminotransferase,
the presence of type II diabetes, a history of heavy alcohol
consumption, and ultrasonographic steatosis signs (12).
In the present study, we found that an AUROC curve of
0.94 provided an excellent tool for BMI-associated steatotic
diagnosis. The AUROC curve area revealed an optimal BMI
cut-off value of 27.5 kg/m2 with a sensitivity of 100%,
specificity of 87%, and negative predictive value of 100%.
During organ recovery surgery, inspection at procurement
facilitates detection of the degree of liver steatosis. However,
a poor correlation exists between surgical assessment and the
degree of steatosis when the degree of steatosis is 435%.
A biopsy should then be systematically performed (5). In this
study, difficulties were encountered in evaluating liver steato-
sis at advanced stages and performing correlations with severe
fatty infiltration of the pancreas.
Table 3 - Gamma ordinal association between categorical variables.
Factor 01 Factor 02 Gamma 95% CI
Pancreas, macro Pancreas, micro 0.04 [-0.44; 0.52]
Liver, macro Liver, micro 0.18 [-0.33; 0.7]
Pancreas, macro Liver, macro 0.98 [0.95; 1]
Pancreas, micro Liver, micro 0.52 [0.04; 1]
Note: CI, confidence interval; Surgeon, macroscopy (macro); Pathology, microscopy (micro).
Table 4 - Multiple comparison tests for donor body mass index variables.
Factor Group comparison %/n p-value
Liver, surgeon Mild vs. Absent 39.2 (n=21) vs. 42.8 (n=23) 0.189
Moderate vs. Absent 14.2 (n=8) vs. 42.8 (n=23) 0.030
Moderate vs. Mild 14.2 (n=8) vs. 39.2 (n=21) 0.349
Mild vs. Absent 39.2 (n=21) vs. 42.8 (n=23) 0.313
Moderate vs. Absent 14.2 (n=8) vs. 42.8 (n=23) 0.238
Liver, pathology Severe vs. Absent 8 (n=4) vs. 40 (n=22) o0.001
Moderate vs. Mild 10 (n=5) vs. 42 (n=23) 0.999
Severe vs. Mild 8 (n=4) vs. 42 (n=23) o0.001
Severe vs. Moderate 8 (n=4) vs. 10 (n=5) o0.001
Note: BMI, Body mass index; Surgeon, macroscopy; Pathology, microscopy.
Table 2 - Multiple comparison tests for all parameters and groups.
Parameters Organ Severity Median (25%-75%) p-value
Surgeon Pathology
Donor age Pancreas Absent 40 (28 - 49.25) 33.5 (15.75 - 40) 0.399
Mild 50.5 (34.75 - 57.75) 45 (34 - 54) 0.565
Moderate 44 (31.5 - 58) 48 (35.5 - 57.5) 0.999
Severe 54.5 (51.25 - 57.75) - -
Liver Absent 43.5 (28 - 50.5) 40 (18.25 - 52) 0.999
Mild 49 (39 - 59.5) 42.5 (36.25 - 56) 0.517
Moderate 53 (40.5 - 63.25) 48 (48 - 50) 0.902
Severe - 38 (30.25 - 45) -
Donor BMI Pancreas Absent 21.8 (19.45 - 26.02) 21.6 (20.25 - 22.57) 0.707
Mild 25.15 (24.18 - 26.85) 24.2 (22.7 - 27.2) 0.353
Moderate 23.7 (21.08 - 24.65) 24.7 (23.75 - 24.9) 0.609
Severe 25.6 (24.2 - 27) - -
Liver Absent 21.8 (19.45 - 26.1) 22.45 (19.73 - 24.88) 0.885
Mild 24.7 (23.95 - 26.55) 24.2 (23.12 - 26.73) 0.411
Moderate 27.2 (25.3 - 30.75) 25.1 (25.1 - 25.7) 0.268
Severe - 32.8 (27.73 - 37.85) -
Note: Median and interquartile range (25%-75%); BMI, Body mass index; Surgeon, macroscopy; Pathology, microscopy.
4
Liver biopsy may facilitate pancreatic graft evaluation
Nacif LS et al.
CLINICS 2018;73:e49
Criteria of liver texture (yellowness, round edges, and an
absence of capsular scratch marks) were associated with and
were more helpful in identifying macrosteatotic organs than
the actual steatosis estimation by the surgeon (3). This impor-
tant point could help surgeons to classify liver steatosis;
however, in this study, we described a new classification
of PGAI with subclassifications of absent, mild, moderate,
and severe.
Improved allocation management also helps to adjust wait-
ing time and establish a uniform pancreas allocation policy.
Under current allocation policy, waiting time accrued by
pancreas-alone candidates will not be considered in the list-
ing for concurrent kidney-pancreas or kidney-alone trans-
plants (8). Furthermore, rates of pancreatic graft acceptance
have demonstrated a significant decrease in recent years
(from 46.4% to 25% [po0.05]), and despite greater organ
availability, pancreatic transplants have remained stable (13).
This study described new pancreatic macroscopic and micro-
scopic evaluations of graft adipose infiltration aimed at
improving organ acceptance and allocation.
This study had several limitations: 1) it was a single-center
study with a relatively small sample size; 2) because this
was a clinical practice study, all liver grafts that were trans-
planted were included; therefore, a few cases with severe
steatosis or severe pancreatic infiltration, and 3) cross-
sectional macroscopic and microscopic analysis of the pancreas
and liver were performed. Furthermore, an important benefit
of this study was obtaining information about the association
between the degree of steatosis and fatty infiltration of the
pancreatic graft in multiple deceased donor organs, which
could result in better allocation of the pancreatic graft based
on the liver biopsy. However, we did not evaluate the trans-
plant outcome correlations.
In conclusion, positive associations of macroscopic and
microscopic histopathological findings in steatotic livers and
adipose infiltration of the pancreatic graft were observed.
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